Geneva Partners’s ASML ASML Stock Holding History

Geneva Partners’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$283K	Sell	156 -1,728	-92%	-$3M	0.08%	77
2026 Q2	$3.75M	Buy	+1,884	New	+$3M	1%	31
2024 Q3	–	Sell	-3,285	Closed	-$3.36M	–	71
2024 Q2	$3.36M	Buy	3,285 +1,383	+73%	+$1.33M	1.38%	29
2024 Q1	$1.85M	Buy	+1,902	New	+$1.69M	0.81%	37
2023 Q3	–	Sell	-7,013	Closed	-$5.08M	–	66
2023 Q2	$5.08M	Buy	7,013 +1,877	+37%	+$1.28M	3.32%	13
2023 Q1	$3.5M	Buy	+5,136	New	+$3.3M	2.99%	13
2018 Q1	–	Sell	-5,230	Closed	-$909K	–	79
2017 Q4	$909K	Sell	5,230 -150	-3%	-$26.5K	0.68%	54
2017 Q3	$921K	Buy	+5,380	New	+$824K	0.73%	48

Other funds holding ASML

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Hyperion Asset Management Brisbane, Australia $3.66B AUM 10.02% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geneva Partners's ASML Position: Q3 2026 in Review

Geneva Partners reduced its ASML (ASML) stake by 92% in Q3 2026, selling an estimated $3M and leaving 156 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #77.

Geneva Partners first reported a position in ASML in Q3 2017 and has held it in 8 quarters since. The position peaked at $5.08M in Q2 2023. 1,422 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

Geneva Partners held 156 shares of ASML worth $283K as of Q3 2026.
Geneva Partners sold 1,728 ASML shares in Q3 2026, an estimated $3M.
ASML made up 0.08% of Geneva Partners's portfolio in Q3 2026, its #77 holding.
Geneva Partners first reported a position in ASML in Q3 2017 and has held it in 8 quarters since.
Geneva Partners's ASML position peaked at $5.08M in Q2 2023.
1,422 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.